NEW — Find ETPs by name, index, sector/industry, or holdings. This new feature allows you to see a list of ETPs containing key words such as gold, oil, or natural gas, enabling you to invest by theme. Learn more.

Snapshot: FHLC

FIDELITY MSCI HEALTH CARE INDEXFidelity

27.19up0.13 (0.48%)

 as of 10:20:04am ET 04/21/2014
Bid --
Bid Size --
Ask --
Ask Size --
Open 27.15
High 27.25
Low 27.09
Previous Close 27.06
Price Performance (Last 52 Wk) --
Volume 14,749
Volume (90-Day Average) 96,286
Bid / Ask Spread (1 Month Average)
as of 02/28/2014
0.08
Premium / Discount (1 Day)
as of 04/17/2014
0.04%
Premium / Discount (1 Month Rolling Average)
as of 04/17/2014
0.04%
Tracking Error --
NAV (Previous Day)
as of 04/17/2014
27.0463
NAV (Intra-Day) --
Options No
Detailed Quote
CompareChart Options
Compare and Chart Options tabs. Compare tab selected. Advanced Chart Secure. Login required. | Reset Chart
 
S&P 500
DJIA
NASDAQ
Chart
 

ETP Type

ETF

Asset Class

Equity

Geography Objective

US

Capitalization / Style Objective

Broad/Multi Cap / Core or Blend

Sector Objective

Healthcare

Net Assets
AS OF 03/31/2014

$113.3M

Net Expense Ratio

0.12%

Sponsor

Fidelity Management & Research

Inception Date

10/21/2013

Investment Philosophy

Passive Index

Benchmark Index

MSCI USA IMI Health Care Index

Index Composition

Cap-Weighted

Legal Structure

Open-End Investment Company

Basket Total Holdings

287

Objective

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. Investing at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care Index. The fund is non-diversified.

Learn More

News, Commentary & Events

Log in for more news
Error

Sorry : There are currently no news stories available for this symbol.

  • Fast and furious selloff provides important market cleansing

    BY Scott Martindale, Sabrient - 04/14/2014

    The sudden bearish turn last week has come fast and furious as selloffs are wont to do. And the pullback might have further still to go. But there are several reasons to expect a stabilization or bounce during this holiday-shortened week, and in any case I still expect that it eventually will turn out to be a great buying opportunity leading to higher prices later in the year. No doubt, investors have been protecting capital, and there has been a rotation into the blue chips as the momentum darlings have been slaughtered. A market cleansing like this is both important and inevitable; however, as I observed last week, the market will often throw out the proverbial baby with the bathwater. Overall, this week's fundamentals-based rankings have returned to a neutral bias. Our Sector Rotation Model suggests holding Technology, Healthcare, and Utilities. Also discussed are some highly-ranked ETFs and individual stock ideas from within the top-ranked sectors, and what the model suggests if you have a bearish outlook.

  • Sector Detector: Rankings take a bearish turn as the flight to safety solidifies

    BY Scott Martindale, Sabrient - 04/07/2014

    Although the large caps set new highs early on Friday, small caps and Nasdaq have not come close to their prior highs. Friday closed with extreme weakness across the board, and it was on high volume. The technical picture and our fundamentals-based sector rankings have both taken a bearish turn, so we might see more weakness ahead. But longer term, I expect higher prices, so an extended pullback likely will turn into a good buying opportunity. In any case, the rotation from speculative stocks into higher quality companies should continue. Indeed, the momentum darlings from biotech, internet, and social media have taken a severe hit, along with many of the highly popular but lower quality/overvalued stocks. Overall, this week's fundamentals-based rankings have taken a bearish turn, with Utilities rising to the top and with Financial and Basic Materials showing marked weakness. Our Sector Rotation Model suggests holding Technology, Healthcare, and Energy in the current bullish climate. Also discussed are some highly-ranked ETFs and individual stock ideas from within the top-ranked sectors, and what the model suggests if you have a neutral or bearish outlook.

Analyst Opinions

Analyst Ratings

LAST CHANGE
Firm Name As of Date Action Rating Report
Ned Davis Research, Inc. 11/29/2013 -- Log in for rating & report
S&P Capital IQ 04/19/2014 Downgrade Log in for rating & report
More Analyst Opinions

Key Statistics

Price / Earnings (Trailing Twelve Months) 24.02
Price / Book 3.75
Price / Sales 1.86
Price / Cash Flow 16.10
30-day SEC Yield --
Distribution Yield (TTM)
AS OF 03/31/2014
--
See all Key Stats

Compare

FHLC
FIDELITY MSCI HEALTH CARE INDEX
Asset Class Median
Volume (10-Day Avg)
AS OF 04/17/2014
86.6K 28.2M
1 Week Market Total Return
AS OF 04/18/2014
+0.71% +1.06%
1 Month Market Total Return
AS OF 04/18/2014
-4.28% +1.10%
1 Year Market Total Return
AS OF 04/18/2014
-- +20.54%
3 Year Annualized Market Total Return
AS OF 04/18/2014
-- +9.20%
Beta (1 Year Month-End)
AS OF 03/31/2014
-- 0.99
Annual Turnover Ratio
AS OF --
-- 21.00%
Net Expense Ratio
AS OF 03/31/2014
0.12% 0.58%
Compare to Other ETFs

Performance

Growth of Hypothetical $10,000 * AS OF 03/31/2014

Cumulative Total Returns AS OF 04/17/2014
NAV Return Market Return S&P 500 Index
YTD +2.13% +1.98% +1.49%
4 Weeks -4.30% -4.28% +0.46%
13 Weeks -1.58% -1.57% +1.95%
26 Weeks -- -- +8.71%
Quarter-End Average Annual Total Returns AS OF 03/31/2014
NAV Return Market Return
1 Year -- --
3 Year -- --
5 Year -- --
10 Year -- --
Life +12.49% +11.56%
Life as of inception date: 10/21/2013       Gross Expense Ratio: 0.12%

The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.

More about Performance & Risk

Portfolio Composition

Top 10 Basket Holdings AS OF 04/17/2014

View all Basket Holdings
JNJ Johnson & Johnson 10.78%
PFE Pfizer Inc 7.57%
MRK Merck & Co Inc 6.37%
GILD Gilead Sciences Inc 4.14%
AMGN Amgen Inc 3.36%
BMY Bristol-Myers Squibb Co 3.15%
ABBV AbbVie Inc 2.98%
UNH UnitedHealth Group Inc 2.95%
BIIB Biogen Idec Inc 2.64%
LLY Eli Lilly and Co 2.36%
†Part or all of this cash position may represent cash-in-lieu of marketable securities and not actual cash.Click here for more information.More about Portfolio Composition

StyleMap®

as of 04/17/2014 More information
Value Blend Growth
Large StyleMap: Large Growth
Mid
Small
Current HistoricalCurrent Fund Assets Coverage: 100%
Data provided by . More about Portfolio Composition
Free commission offer applies to online purchases of 65 iShares® ETFs and Fidelity ETFs in a Fidelity brokerage account with a minimum opening balance of $2,500. The sale of ETFs are subject to an activity assessment fee (of between $0.01 to $0.03 per $1000 of principal) by Fidelity. After September 30, 2013, 65 iShares ETFs are subject to a short-term trading fee by Fidelity, if held less than 30 days. After January 31, 2014, Fidelity ETFs are subject to a short-term trading fee by Fidelity, if held less than 30 days. See the brokerage commission and fee schedule (PDF) for details. *The chart illustrates the NAV performance of a hypothetical $10,000 investment made in the fund on 12/31/1999 or on commencement of operations (whichever is later). Figures include reinvestment of capital gains and dividends, but do not reflect the effect of any applicable sales charges or redemption fees, which would lower these figures. This chart is not intended to imply any future performance of the fund.

**The Overall Morningstar RatingTM for a fund is derived from a weighted average of the performance figures associated with its three-, five-, and ten-year (if applicable) Morningstar Rating metrics. For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a funds monthly performance (including the effects of sales charges, loads and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund within this scale and rated separately, which may cause slight variations in the distribution percentages.)

The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance. Average annual total returns are historical and include change in share value and reinvestment of dividends and capital gains, if any. Cumulative total returns are reported as of the period indicated. Life of fund figures are reported as of the commencement date to the period indicated. Since ETFs are bought and sold at prices set by the market - which can result in a premium or discount to NAV- the returns calculated using market price (market return) can differ from those calculated using NAV (NAV return).

Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive, long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Additional information about the sources, amounts, and terms of compensation is described in the ETFs prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.